Clinical Trial Update: Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional Mitral Regurgitation (The COAPT Trial) and COAPT CAS [NA]

View source ↗

Summary

Clinical trial update for the COAPT study and COAPT CAS, assessing cardiovascular outcomes of MitraClip in heart failure patients with functional mitral regurgi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Functional Mitral Regurgitation
• Heart Failure
• Mitral Regurgitation

Drugs mentioned

• MitraClip

Snippet

Sponsor: Abbott Medical Devices | Conditions: Mitral Regurgitation, Mitral Valve Regurgitation | NA | Status: UNKNOWN | Results posted: 2020-05-06